Director
NYU Langone Center for Psychedelic Medicine
New York University Grossman School of Medicine, New York
Dr. Bogenschutz is a Professor of Psychiatry at NYU Grossman School of Medicine and director of the NYU Langone Center for Psychedelic Medicine. He is an addiction psychiatrist with over 20 years of experience conducting NIH-funded research on pharmacological and behavioral treatments for addictions and co-occurring psychiatric disorders. Prior to joining the faculty at NYU Grossman School of Medicine in 2015, he was Vice-chair for Addiction Psychiatry at the University of New Mexico, where he established and directed an addiction psychiatry fellowship and for 10 years served as the PI of the Southwest Node of the NIDA Clinical Trials Network. Over the past decade he has investigated the therapeutic potential of serotonergic psychedelic drugs such as psilocybin and MDMA. He has completed two trials of psilocybin-assisted treatment for alcohol use disorder, and currently site PI for a 3-site NIDA-funded trial of psilocybin in the treatment of tobacco use disorder. He is also engaged in NIAAA-funded research on non-psychedelic pharmacotherapies, focusing on efficacy as well neural mechanisms and the use of machine learning strategies to identify likely responders.
Disclosure information not submitted.
Psychedelics for the Treatment of Alcohol Use Disorder
Friday, October 18, 2024
9:10 AM – 9:30 AM ET
